DEFA14A ·Filed Apr 28, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor the outcome of the annual meeting on June 24 for any unexpected vote results; this is a routine filing with no immediate trading catalyst.
Final — all horizons settled through T+60d
GANX ▼ -0.57% at T+60d
NEUTRAL call -0.57% · α vs SPY -4.68% · entry $1.76 → $1.75
T+1d
+7.39%
call +7.39% · α +6.36%
$1.89
settled 6mo ago
T+5d
+8.52%
call +8.52% · α +5.41%
$1.91
settled 6mo ago
T+20d
+14.77%
call +14.77% · α +8.72%
$2.02
settled 5mo ago
T+60d
-0.57%
call -0.57% · α -4.68%
$1.75
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Gain Therapeutics filed definitive additional proxy materials (DEFA14A) for its 2026 annual meeting, recommending stockholders vote FOR the election of seven director nominees and FOR ratification of Ernst & Young AG as independent auditor. The meeting is scheduled for June 24, 2026.
Key Financial Metrics
Vote
director election
Meeting
2026-06-24
Key Facts
- Annual meeting set for June 24, 2026 at 8:30 a.m. Eastern Time
- Board recommends FOR all 7 director nominees: Gene Mack, Khalid Islam, Dov Goldstein, Hans Peter Hasler, Gwen Melincoff, Claude Nicaise, Jeffrey Riley
- Proposal 2: Ratify Ernst & Young AG as auditor for FY2026
- Proxy materials available at https://web.viewproxy.com/GANX/2026
- Stockholders must use virtual control number to vote or attend meeting
Financial Impact
No financial impact from this routine proxy solicitation
Risk Factors
- Low risk of shareholder dissent on director elections or auditor ratification
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-050435 |
| Document: 0001104659-26-050435-index-headers.html | 0001104659-26-050435 |
| Document: 0001104659-26-050435-index.html | 0001104659-26-050435 |
| Document: 0001104659-26-050435.txt | 0001104659-26-050435 |
11 reports for GANX
33% Hit rate @ T+5 Went positive at some point 3 of 6 best @ T+60▲ +13.74%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | Press Release | $1.72 $1.62 | ▼ −6.10% | ▼ −7.41% | $1.17 (−31.98%) |
Oct 1, 2026 26d ago | 8-K | $1.72 $1.62 | ▼ −6.10% | ▼ −7.41% | $1.17 (−31.98%) |
Aug 11, 2026 11w ago | Press Release | $2.06 $2.03 | ▼ −1.46% | ▼ −1.05% | $1.17 (−43.20%) |
Jul 16, 2026 14w ago | 8-K | $1.66 $1.82 | ▲ +9.64% | ▲ +11.31% | $1.17 (−29.52%) |
Jun 29, 2026 17w ago | 8-K | $2.03 $1.81 | ▼ −10.84% | ▼ −11.44% | $1.17 (−42.36%) |
Jun 29, 2026 17w ago | Press Release | $2.03 $1.81 | ▼ −10.84% | ▼ −11.44% | $1.17 (−42.36%) |
May 26, 2026 22w ago | 8-K | $1.82 $1.96 | ▲ +7.69% | ▲ +6.61% | $1.17 (−35.71%) |
May 11, 2026 24w ago | Press Release | $1.82 $1.62 | ▼ −10.99% | ▼ −10.90% | $1.17 (−35.71%) |
Apr 28, 2026 26w ago | DEFA14A | $1.76 $1.91 | ▲ +8.52% | ▲ +5.41% | $1.17 (−33.52%) |
Mar 26, 2026 30w ago | Press Release | $1.89 $1.85 | ▼ −2.12% | ▼ −3.75% | $1.17 (−38.10%) |
Showing 10 of 11
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers